» Authors » Piotr Zapala

Piotr Zapala

Explore the profile of Piotr Zapala including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 48
Citations 273
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Torun A, Zdanowicz A, Miazek-Zapala N, Zapala P, Pradhan B, Jedrzejczyk M, et al.
Haematologica . 2024 Dec; PMID: 39704178
Our investigation uncovers that nanomolar concentrations of salinomycin, monensin, nigericin, and narasin (a group of potassium/sodium cation carriers) robustly enhance surface expression of CD20 antigen in B-cell-derived tumor cells, including...
2.
Rajwa P, Zapala P, Merseburger A
Eur Urol Focus . 2024 Aug; PMID: 39107195
There have been significant advances in our understanding of the biology of metastatic prostate cancer (mPCa) and its response to therapy. Androgen receptor (AR) alterations, including mutations, amplifications, splice variants,...
3.
Slusarczyk A, Wolanski R, Milow J, Piekarczyk H, Lipinski P, Zapala P, et al.
Biomedicines . 2024 Jul; 12(7). PMID: 39062114
Radical cystectomy (RC) remains a mainstay surgical treatment for non-metastatic muscle-invasive and BCG-unresponsive bladder cancer. Various perioperative scoring tools assess comorbidity burden, complication risks, and cancer-specific mortality (CSM) risk. We...
4.
Garbas K, Zapala L, Slusarczyk A, Piecha T, Gwara P, Zuk-Lapan A, et al.
Int Urol Nephrol . 2024 May; 56(11):3485-3494. PMID: 38819576
Purpose: Our study aimed to develop a noninvasive model using a combination of the set of clinical data and uroflowmetry (UFL) to differentiate between detrusor underactivity (DU) and bladder outlet...
5.
Slusarczyk A, Ismail H, Zapala L, Piecha T, Zapala P, Radziszewski P
Ann Surg Oncol . 2024 Apr; 31(7):4773-4786. PMID: 38570378
Background: This study aimed to characterize the urinary and tumor microbiomes in patients with non-muscle-invasive bladder cancer (NMIBC) before and after transurethral resection of the bladder tumor (TURBT). Methods: This...
6.
Zapala P, Slusarczyk A, Zapala L, Borkowski T, Rajwa P, Niemczyk G, et al.
Cent European J Urol . 2024 Jan; 76(4):293-299. PMID: 38230322
Introduction: This study aimed to evaluate cancer-specific (CSM) and other-cause mortality (OCM) in elderly patients with prostate cancer treated with radical prostatectomy (RP) and postoperative radiotherapy (RT). Material And Methods:...
7.
Slusarczyk A, Zapala P, Piecha T, Zapala L, Borkowski T, Radziszewski P
Ann Surg Oncol . 2023 Dec; 31(3):2144-2153. PMID: 38085392
Background: Systemic and local recurrences of urothelial bladder cancer (UBC) significantly impair survival after radical cystectomy (RC), but little is known about the impact of the recurrence of urothelial cancer...
8.
Hanusz K, Domanski P, Strojec K, Zapala P, Zapala L, Radziszewski P
Biomedicines . 2023 Nov; 11(11). PMID: 38001942
Prostate cancer (PCa) is a low tumor mutational burden (TMB) cancer with a poor response to immunotherapy. Nonetheless, immunotherapy can be useful, especially in metastatic castration-resistant PCa (mCRPC). Increased cytotoxic...
9.
Slusarczyk A, Zapala P, Zapala L, Rajwa P, Moschini M, Laukhtina E, et al.
Urol Oncol . 2023 Nov; 42(1):22.e1-22.e11. PMID: 37981503
Purpose: Although kidney-sparing surgery (KSS) is a nonminor option for low-risk upper urinary tract urothelial cancer (UTUC), its oncological benefits in high-risk UTUC remain unclear when compared to radical nephroureterectomy...
10.
Slusarczyk A, Zapala P, Piecha T, Rajwa P, Moschini M, Radziszewski P
Cancers (Basel) . 2023 Sep; 15(18). PMID: 37760628
The benefit of lymph node dissection (LND) during radical nephroureterectomy (RNU) in lymph node (LN)-negative (cN0/pN0) UTUC remains controversial. We aimed to assess the association between LND and its extent...